A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A).
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D002339:Carotid Arteries; D003094:Collagen / Q000494:pharmacology; D004285:Dogs; D004560:Electricity / Q000009:adverse effects; D005343:Fibrinolytic Agents; D000882:Haplorhini; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007834:Lasers; D008253:Macaca mulatta; D010974:Platelet Aggregation / Q000187:drug effects*; D011799:Quinazolines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013927:Thrombosis / Q000209:etiology
D005343:Fibrinolytic Agents; D007093:Imidazoles; D011799:Quinazolines; D000244:Adenosine Diphosphate; D003094:Collagen; C021139:anagrelide